- Home
- MREO vs HIX Comparison
MREO vs HIX Comparison
Compare MREO & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- HIX
- Stock Information
- Founded
- MREO 2015
- HIX 1998
- Country
- MREO United Kingdom
- HIX United States
- Employees
- MREO N/A
- HIX N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- HIX Finance/Investors Services
- Sector
- MREO Health Care
- HIX Finance
- Exchange
- MREO Nasdaq
- HIX Nasdaq
- Market Cap
- MREO 438.8M
- HIX 382.6M
- IPO Year
- MREO N/A
- HIX N/A
- Fundamental
- Price
- MREO $2.87
- HIX $4.35
- Analyst Decision
- MREO Strong Buy
- HIX
- Analyst Count
- MREO 5
- HIX 0
- Target Price
- MREO $7.60
- HIX N/A
- AVG Volume (30 Days)
- MREO 1.3M
- HIX 449.5K
- Earning Date
- MREO 08-12-2025
- HIX 01-01-0001
- Dividend Yield
- MREO N/A
- HIX 13.14%
- EPS Growth
- MREO N/A
- HIX N/A
- EPS
- MREO N/A
- HIX N/A
- Revenue
- MREO N/A
- HIX N/A
- Revenue This Year
- MREO N/A
- HIX N/A
- Revenue Next Year
- MREO $52.34
- HIX N/A
- P/E Ratio
- MREO N/A
- HIX N/A
- Revenue Growth
- MREO N/A
- HIX N/A
- 52 Week Low
- MREO $1.58
- HIX $4.16
- 52 Week High
- MREO $5.02
- HIX $5.08
- Technical
- Relative Strength Index (RSI)
- MREO 61.43
- HIX 70.20
- Support Level
- MREO $2.63
- HIX $4.28
- Resistance Level
- MREO $2.85
- HIX $4.26
- Average True Range (ATR)
- MREO 0.16
- HIX 0.04
- MACD
- MREO -0.01
- HIX 0.01
- Stochastic Oscillator
- MREO 79.41
- HIX 97.06
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.